# An Extended-Release Form of Clonidine as an Anti-Manic Agent: An Add-on, Open-Label Study

> **NCT03065933** · PHASE4 · TERMINATED · sponsor: **Mclean Hospital** · enrollment: 5 (actual)

## Conditions studied

- Bipolar Disorder, Mania

## Interventions

- **DRUG:** extended-release clonidine

## Key facts

- **NCT ID:** NCT03065933
- **Lead sponsor:** Mclean Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-01
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2017-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03065933

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03065933, "An Extended-Release Form of Clonidine as an Anti-Manic Agent: An Add-on, Open-Label Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03065933. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*